Comparison 7. Biodentine pulpotomy versus Mineral trioxide aggregate (MTA) pulpotomy.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Clinical failure	4		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
1.1 6 months	4	234	Risk Ratio (M‐H, Fixed, 95% CI)	1.72 [0.42, 6.99]
1.2 12 months	2	144	Risk Ratio (M‐H, Fixed, 95% CI)	0.75 [0.16, 3.62]
2 Radiological failure	4		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
2.1 6 months	4	234	Risk Ratio (M‐H, Fixed, 95% CI)	2.40 [0.65, 8.84]
2.2 12 months	2	144	Risk Ratio (M‐H, Fixed, 95% CI)	1.08 [0.22, 5.27]
3 Pain	3		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
3.1 6 months	3	180	Risk Ratio (M‐H, Fixed, 95% CI)	5.0 [0.26, 98.00]
4 Soft tissue pathology	3		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
4.1 6 months	3	180	Risk Ratio (M‐H, Fixed, 95% CI)	5.0 [0.26, 98.00]
5 Pathologic mobility	3		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
5.1 6 months	3	180	Risk Ratio (M‐H, Fixed, 95% CI)	5.0 [0.26, 98.00]
6 Pathological radiolucency	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
6.1 6 months	2	144	Risk Ratio (M‐H, Fixed, 95% CI)	3.46 [0.15, 81.36]
6.2 12 months	2	144	Risk Ratio (M‐H, Fixed, 95% CI)	1.09 [0.19, 6.27]
7 Pathological root resorption	2		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
7.1 6 months	2	144	Risk Ratio (M‐H, Fixed, 95% CI)	2.32 [0.22, 24.09]
7.2 12 months	2	144	Risk Ratio (M‐H, Fixed, 95% CI)	1.12 [0.30, 4.19]